Recent evidence has also hinted that the nucleus may play a role in degradation through the involvement of promyelocytic leukemia-nuclear bodies (PML-NB), comprised of PML and Sp100 proteins, in a process that sumoylates Nrf2 to render it susceptible to SUMO-targeting ubiquitin ligases [44]. The gene discussed is PML; the disease is leukemia.